Back to dashboard
MedicaidCoverageMedium impact

Updated Guidance on the Use of Misoprostol

Maryland Medicaid·MD · OB-GYN, Gastroenterology, Family Medicine +1 more·Provider Transmittal
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Maryland Medicaid has issued updated guidance on the use of Misoprostol, a medication commonly used for various gynecological and gastroenterological conditions. This provider transmittal likely contains changes to coverage criteria, prior authorization requirements, or billing guidelines specific to Maryland Medicaid patients receiving Misoprostol treatment.

Action Required

Action needed
Immediately: Billing and clinical staff should review the complete Maryland Medicaid Provider Transmittal PT 33-22 at the source URL to understand specific changes to Misoprostol coverage, billing requirements, or prior authorization criteria. Update billing procedures and clinical protocols accordingly for Maryland Medicaid patients requiring Misoprostol treatment.
Updated Guidance on the Use of Misoprostol | Maryland Medicaid | PolicyChanges.app